OXT and obesity due to melanocortin 4 receptor deficiency: All of the evidence points to intranasal oxytocin as a special agent that combats obesity by improving body composition and metabolism, reducing appetite by rebalancing brain reward and control pathways, and possibly altering gut-brain and emotional pathways (Table 1).